Seyedarad Mosalamiaghili, Hamideh Akbari, Narges Lashkarbolouk, Ali Ariannia, Mahshid Mehrjerdian, Fatemeh Salamat, & Mahdi Mazandarani. (2025). Effects of Fibroblast Growth Factor 21 Serum Level on Clinicopathological Findings in Papillary Thyroid Carcinoma. Babol University of Medical Sciences.
Chicago Style (17th ed.) CitationSeyedarad Mosalamiaghili, Hamideh Akbari, Narges Lashkarbolouk, Ali Ariannia, Mahshid Mehrjerdian, Fatemeh Salamat, and Mahdi Mazandarani. Effects of Fibroblast Growth Factor 21 Serum Level on Clinicopathological Findings in Papillary Thyroid Carcinoma. Babol University of Medical Sciences, 2025.
MLA (9th ed.) CitationSeyedarad Mosalamiaghili, et al. Effects of Fibroblast Growth Factor 21 Serum Level on Clinicopathological Findings in Papillary Thyroid Carcinoma. Babol University of Medical Sciences, 2025.